Cargando…

Quercetin in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies

Alzheimer’s disease (AD) is the leading cause of dementia worldwide. It involves progressive impairment of cognitive function. A growing number of neuroprotective compounds have been identified with potential anti-AD properties through in vitro and in vivo models of AD. Quercetin, a natural flavonoi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiao-Wen, Chen, Jia-Yue, Ouyang, Defang, Lu, Jia-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014205/ https://www.ncbi.nlm.nih.gov/pubmed/31941000 http://dx.doi.org/10.3390/ijms21020493

Ejemplares similares

Ferulic Acid in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies
por: Wang, Er-Jin, et al.
Publicado: (2021)

Disease-Modifying Activity of Huperzine A on Alzheimer’s Disease: Evidence from Preclinical Studies on Rodent Models
por: Yan, Ye-Piao, et al.
Publicado: (2022)

Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies
por: Yuan, Ning-Ning, et al.
Publicado: (2019)

Effect of acupuncture on neuroinflammation in animal models of Alzheimer’s disease: A preclinical systematic review and meta-analysis
por: Wu, Zhi-Guo, et al.
Publicado: (2023)

Verum- versus Sham-Acupuncture on Alzheimer's Disease (AD) in Animal Models: A Preclinical Systematic Review and Meta-Analysis
por: Zhao, Fei-Yi, et al.
Publicado: (2020)

Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer’s disease: a meta-analysis and systematic review
por: Liu, Wei-Lin, et al.
Publicado: (2022)

Neuroprotective Effects of Quercetin in Alzheimer’s Disease
por: Khan, Haroon, et al.
Publicado: (2019)

Oral Administration of Quercetin or Its Derivatives Inhibit Bone Loss in Animal Model of Osteoporosis
por: Huang, Yue-Yue, et al.
Publicado: (2020)

Protective Effect and Possible Mechanisms of Astragaloside IV in Animal Models of Diabetic Nephropathy: A Preclinical Systematic Review and Meta-Analysis
por: Wang, Hong, et al.
Publicado: (2020)

Quercetin Nanoemulsion Ameliorates Neuronal Dysfunction in Experimental Alzheimer’s Disease Model
por: Alaqeel, Nouf K., et al.
Publicado: (2022)

Synergistic effects of quercetin and regular exercise on the recovery of spatial memory and reduction of parameters of oxidative stress in animal model of Alzheimer's disease
por: Molaei, Amin, et al.
Publicado: (2020)

Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies
por: Shineman, Diana W, et al.
Publicado: (2011)

Effectiveness and mechanism of metformin in animal models of pulmonary fibrosis: A preclinical systematic review and meta-analysis
por: Wu, Xuanyu, et al.
Publicado: (2022)

Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer’s disease
por: Liang, Hai-Yong, et al.
Publicado: (2021)

Protective effects and mechanism of curcumin in animal models of pulmonary fibrosis: a preclinical systematic review and meta-analysis
por: Hanyu, Fang, et al.
Publicado: (2023)

Preclinical animal models of COPD
por: Vlahos, Ross
Publicado: (2013)

Allopregnanolone Promotes Regeneration and Reduces β-Amyloid Burden in a Preclinical Model of Alzheimer's Disease
por: Chen, Shuhua, et al.
Publicado: (2011)

Shexiang Baoxin Pills for Coronary Heart Disease in Animal Models: Preclinical Evidence and Promoting Angiogenesis Mechanism
por: Zhang, Ke-Jian, et al.
Publicado: (2017)

Preventive Effect of Quercetin in a Triple Transgenic Alzheimer’s Disease Mice Model
por: Paula, Pérez-Corredor, et al.
Publicado: (2019)

Candidate Animal Disease Model of Elizabethkingia Spp. Infection in Humans, Based on the Systematic Pathology and Oxidative Damage Caused by E. miricola in Pelophylax nigromaculatus
por: Huang, Xiaoli, et al.
Publicado: (2019)

APP mouse models for Alzheimer's disease preclinical studies
por: Sasaguri, Hiroki, et al.
Publicado: (2017)

Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences
por: de Andrade Teles, Roxana Braga, et al.
Publicado: (2018)

Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies
por: Andrade, Stephanie, et al.
Publicado: (2019)

Preclinical Evidence and Mechanism of Xingnaojing Injection for Cerebral Ischemia: A Systematic Review and Meta-Analysis of Animal Studies
por: Ma, Rong, et al.
Publicado: (2018)

Animal Models of Alzheimer's Disease
por: Casadesus, Gemma, et al.
Publicado: (2011)

Can acupuncture reverse oxidative stress and neuroinflammatory damage in animal models of vascular dementia?: A preclinical systematic review and meta-analysis
por: Wen, Qin, et al.
Publicado: (2023)

Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage
por: Qin, Wei, et al.
Publicado: (2022)

Network Pharmacology-Based and Experimental Identification of the Effects of Quercetin on Alzheimer’s Disease
por: Qi, Pingfang, et al.
Publicado: (2020)

Human stem cells prevent flap necrosis in preclinical animal models: A systematic review
por: Avila, Francisco R., et al.
Publicado: (2022)

Preclinical in vivo animal models of intervertebral disc degeneration. Part 1: A systematic review
por: Poletto, Daniel L., et al.
Publicado: (2022)

Preclinical Animal Models in Facial Transplantation
por: Ramly, Elie P., et al.
Publicado: (2019)

The Usefulness of Systematic Reviews of Animal Experiments for the Design of Preclinical and Clinical Studies
por: de Vries, Rob B. M., et al.
Publicado: (2014)

Neural stem/progenitor cell therapy for Alzheimer disease in preclinical rodent models: a systematic review and meta-analysis
por: Zhou, Zijing, et al.
Publicado: (2023)

Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus
por: Kim, Ji-Hye, et al.
Publicado: (2011)

Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis
por: Parnetti, Lucilla, et al.
Publicado: (2019)

Systematic review protocol for assessing central auditory functions of Alzheimer’s disease and its preclinical stages
por: Jayakody, Dona M P, et al.
Publicado: (2020)

Preclinical Efficacy and Mechanisms of Mesenchymal Stem Cells in Animal Models of Autoimmune Diseases
por: Lee, Hong Kyung, et al.
Publicado: (2014)

Dynamic Causal Modeling of Preclinical Autosomal-Dominant Alzheimer’s Disease
por: Penny, Will, et al.
Publicado: (2018)

Preclinical Models for Alzheimer’s Disease: Past, Present, and Future Approaches
por: Akhtar, Ansab, et al.
Publicado: (2022)

Preclinical Research in Glycogen Storage Diseases: A Comprehensive Review of Current Animal Models
por: Almodóvar-Payá, Aitana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9khng1n207re0nvqv5lvpleid0